Immediate Impact

1 from Science/Nature 58 standout
Sub-graph 1 of 24

Citing Papers

Potentials and future perspectives of multi-target drugs in cancer treatment: the next generation anti-cancer agents
2024 Standout
Trastuzumab deruxtecan in patients with metastatic non-small-cell lung cancer (DESTINY-Lung01): primary results of the HER2-overexpressing cohorts from a single-arm, phase 2 trial
2024 Standout
1 intermediate paper

Works of Kimberly E. Allen being referenced

Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non–Small Cell Lung Cancer
2010

Author Peers

Author Last Decade Papers Cites
Kimberly E. Allen 11 25 17 80 76 5 145
Theodora Kanaki 3 40 43 96 7 205
Alberto Fulvi 9 99 134 6 199
Melanie Keil 2 8 25 57 6 169
Susan Eller 14 26 57 7 160
Liang-Kee Goh 10 22 5 6 26 6 84
Miriam Martínez 8 54 76 4 163
Brintha Selvarajah 1 24 1 91 15 4 193
Dalia Elfadl 3 17 16 43 7 215
Amruta Shrikhande 6 52 33 5 153
Borbala Katona 8 1 24 53 6 214

All Works

Loading papers...

Rankless by CCL
2026